T. Roberts
Molecular Biology · Nature · 2007–2017
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 154 citations into it
Whom T. Roberts trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- C. D. Allis (in Molecular Biology)
Papers from T. Roberts's perspective
Ordered by how strongly the researchers T. Roberts trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
- Upstream and downstream of mTOR. (Genes & Development)
- TOR signaling in growth and metabolism. (Cell)
- Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. (Cancer Cell)
- Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer
- Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. (Journal of Clinical Oncology)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
Their papers
- The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. (2007) — 702 citations
- KRAS and YAP1 converge to regulate EMT and tumor survival (2014) — 758 citations
- A histone H3 lysine 27 demethylase regulates animal posterior development (2007) — 798 citations
- Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer (2009) — 2,573 citations
- MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS (2012) — 755 citations
- Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (2007) — 645 citations
- COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation (2010) — 731 citations
- CDK4/6 inhibition triggers anti-tumor immunity (2017) — 1,277 citations